Literature DB >> 26537908

The pharmacokinetic disposition of delta-9-tetrahydrocannabinol and its metabolite in elderly patients with dementia--role of differential presystemic conversion?

Nuggehally R Srinivas1.   

Abstract

Entities:  

Year:  2015        PMID： 26537908     DOI： 10.1007/s00213-015-4138-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  4 in total

Review 1.  Human cannabinoid pharmacokinetics.

Authors:  Marilyn A Huestis
Journal:  Chem Biodivers       Date:  2007-08       Impact factor: 2.408

Review 2.  Pharmacokinetics and pharmacodynamics of cannabinoids.

Authors:  Franjo Grotenhermen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence.

Authors:  Garry Milman; Mateus M Bergamaschi; Dayong Lee; Damodara R Mendu; Allan J Barnes; Ryan Vandrey; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2014-04       Impact factor: 3.681

4.  Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9-tetrahydrocannabinol in older persons with dementia.

Authors:  Amir I A Ahmed; Geke A H van den Elsen; Angela Colbers; Cornelis Kramers; David M Burger; Marjolein A van der Marck; Marcel G M Olde Rikkert
Journal:  Psychopharmacology (Berl)       Date:  2015-03-11       Impact factor: 4.530
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.